Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues
Publication

Publications

Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues

Title
Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues
Type
Article in International Scientific Journal
Year
2009
Authors
Gama, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Gaertner, F
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Alves, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Fernando Schmitt
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 87
Pages: 432-437
ISSN: 0034-5288
Publisher: Elsevier
Other information
Authenticus ID: P-003-E7E
Abstract (EN): Epidermal Growth Factor Receptor (EGFR) has been extensively studied in human breast cancer; however, systematic studies of EGFR protein expression in canine mammary gland tumours are lacking. Therefore, we evaluated its immunohistochemical expression in a series of 136 canine mammary tumours and representative areas of adjacent normal and hyperplastic mammary tissue and investigated a possible correlation between EGFR overexpression and several clinicopathological parameters and survival. In normal and hyperplastic canine mammary glands, EGFR expression was consistently observed in myoepithelial cells, with luminal cells usually negative. In tumour tissues, EGFR overexpression was found in 9 benign (19.6%) and 38 malignant (42.2%) lesions, with EGFR positivity significantly related with malignancy. Besides animal age and tumour size, there were no significant associations between other clinicopathological parameters and EGFR overexpression. On survival analysis, tumours with EGFR overexpression showed a reduced disease-free and overall survival; however these associations failed to reach statistically significant levels.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours (2010)
Article in International Scientific Journal
Queiroga, FL; Pires, I; Lobo, L; Lopes, C
Stepping up from wildlife disease surveillance to integrated wildlife monitoring in Europe (2022)
Article in International Scientific Journal
Cardoso, B; Garcia-Bocanegra, I; Acevedo, P; Caceres, G; Alves, PC; Gortazar, C
Serum and intratumoural GH and IGF-I concentrations: Prognostic factors in the outcome of canine mammary cancer (2010)
Article in International Scientific Journal
Queiroga, FL; Perez Alenza, D; Silvan, G; Pena, L; Lopes, C; Illera, JC
Phenotypic characterization of mastitic Prototheca spp. isolates (2010)
Article in International Scientific Journal
marques, s; silva, e; carvalheira, j; thompson, g
Impact of vaccination with the Anaplasma phagocytophilum MSP4 chimeric antigen on gene expression in the rabbit host (2024)
Article in International Scientific Journal
Moraga-Fernández, A; de Sousa-Blanco, M; Marques, JP; Queirós, J; Fernández-Melgar, R; García-Alvarez, O; Alves, PC; Contreras, M

See all (10)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-17 at 03:26:06 | Privacy Policy | Personal Data Protection Policy | Whistleblowing